Celecoxib in Treating Patients With Precancerous Lesions of the Mouth

NCT00014404 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: celecoxib

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]